Elekta

Founded in 1972 by Lars Leksell and Laurent Leksell, Elekta AB is a Swedish company headquartered in Stockholm that specializes in developing advanced medical tools for the treatment of neurological disorders and cancer. The company's core mission is to ensure that everyone has access to the best cancer care. Elekta's flagship products include the Gamma Knife, a non-invasive surgical tool for managing intracranial lesions, and a comprehensive system for stereotactic neurosurgery. The company operates globally, with over 40 offices worldwide, focusing on neuroscience, radiation therapy, radiosurgery, oncology, and electronic medical records.

Notable figures associated with Elekta include its founders, Lars and Laurent Leksell. The company is publicly traded on Nasdaq Stockholm under the ticker EKTA B. Elekta has achieved significant milestones, such as the widespread adoption of the Gamma Knife and the development of the Elekta Evo, a versatile CT-Linac system. These innovations have solidified Elekta's impact on improving cancer treatment and neurosurgery, making it a leader in medical technology and patient care.